GLP-1 Drugs, Gucci's China Sneaker & EU's Digital Product Passport | F2F Prime Brief

This week on the Fibre2Fashion Prime Weekly Brief, Ananya Mariam Rajesh and Milindra Jadeja cover 7 major stories: GLP-1 weight-loss drugs are reshaping holiday apparel spend. 21% of US households now have a user, and jeans purchases are up 66% among them. https://www.fibre2fashion.com/news/PaidNewsDetail.aspx?news_id=313855 Gucci's $1,000 "The Drip" sneaker is made in China, and it's about technical capability, not cost. https://www.fibre2fashion.com/news/PaidNewsDetail.aspx?news_id=313821 China leads next-gen viscose, backing 12 of 20 commercially available product lines https://www.fibre2fashion.com/news/PaidNewsDetail.aspx?news_id=313851 In-depth: The EU's Digital Product Passport. 49 mandatory data points, a 2028/29 deadline, and why 90% of brands still see it as a burden https://www.fibre2fashion.com/industry-article/prime-articles/11770/digital-product-passport-turning-compliance-into-advantage Plus three quick reads: Bangladesh's jute export revival, India's shirt-led garment export slide, and why sportswear is set to cross $500B by 2030. 1) https://www.fibre2fashion.com/news/PaidNewsDetail.aspx?news_id=313839 2) https://www.fibre2fashion.com/news/PaidNewsDetail.aspx?news_id=313783 3) https://www.fibre2fashion.com/news/PaidNewsDetail.aspx?news_id=313792 Subscribe to Fibre2Fashion for weekly updates on textiles, apparel, fashion, retail, sourcing, trade and supply chains. #TextileIndustry #Fibre2Fashion #DigitalProductPassport #Gucci #Sportswear #Sourcing